You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 125 No. 6, June 1970 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (23)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Diagnosis and Treatment of Beta-Adrenergic Receptor Hyperresponsiveness

A Critical Appraisal

Henry R. Bourne, MD; Pate D. Thomson, MD; Kenneth L. Melmon, MD

Arch Intern Med. 1970;125(6):1063-1066.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Physicians have long puzzled over diagnosis and treatment of patients with irritable or "hyperkinetic" hearts. These patients commonly suffer from labile tachycardia, palpitations, and increased awareness of their heart beat, associated with chest discomfort and varying degrees of intolerance to exercise. The absence of a consistent pattern of organic abnormalities has prevented meaningful classification and diagnosis. Lack of information regarding the natural history and prognosis of the syndrome has made evaluation of therapy virtually impossible.

Therefore, keen interest greeted the suggestion of Frohlich et al1 that at least some of these patients suffer from hyperresponsiveness of their cardiac beta-adrenergic receptors. Although these hyperresponsive patients were not typical of the textbook picture of the hyperkinetic heart syndrome in that most of them had hypertension, the suggestion was attractive because, in addition to illumination of one of the murky areas of diagnostic medicine, it contained a satisfying rationale for therapy with . . . [Full Text PDF of this Article]


Author Affiliations

San Francisco

From the departments of medicine and pharmacology, Cardiovascular Research Institute, and the Division of Clinical Pharmacology, University of California Medical Center, San Francisco.


Footnotes

Received for publication Jan 30, 1970; accepted Feb 19.

Reprint requests to Division of Clinical Pharmacology, University of California Medical Center, San Francisco 94122 (Dr. Melmon).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1970 American Medical Association. All Rights Reserved.